How should a febrile infant be evaluated and managed?

Evaluation and Management of a Febrile Infant

For well-appearing febrile infants aged 8-60 days, use age-stratified risk assessment with inflammatory markers (procalcitonin, CRP, ANC) to guide diagnostic testing and treatment decisions, with lumbar puncture and hospitalization reserved for higher-risk infants based on specific clinical and laboratory criteria. 1

Age-Specific Approach

The 2021 American Academy of Pediatrics guidelines provide the most current evidence-based framework, dividing febrile infants (temperature ≥38.0°C) into three distinct age groups with different management strategies 1, 2:

Infants 8-21 Days Old

• Obtain full sepsis workup including blood culture, urine culture (via catheterization or suprapubic aspiration), and cerebrospinal fluid analysis with culture 1
• Hospitalize all infants in this age group with empiric parenteral antimicrobial therapy (ampicillin plus gentamicin or cefotaxime) 1
• This age group has the highest risk of serious bacterial infection, approaching 13% in neonates 3

Infants 22-28 Days Old

• Risk stratification is critical using inflammatory markers 1, 4
• If procalcitonin, CRP, and absolute neutrophil count are normal AND urinalysis is normal:
  • Lumbar puncture may be deferred through shared decision-making with parents 1
  • Observation without antibiotics is reasonable if close follow-up is assured 1
• If any inflammatory marker is abnormal or urinalysis suggests infection:
  • Obtain CSF for analysis and culture 1
  • Initiate empiric antibiotics (ampicillin plus cefotaxime, with or without gentamicin) 1

Infants 29-60 Days Old

• Use inflammatory markers to identify low-risk infants who can avoid invasive procedures 1, 4
• For low-risk infants (normal procalcitonin, CRP, ANC, and urinalysis):
  • CSF analysis is not routinely required 1
  • Home management with close follow-up is acceptable if parents can monitor and return promptly 1
  • Consider parenteral ceftriaxone if managed at home 1
• For higher-risk infants (abnormal inflammatory markers):
  • Obtain blood and urine cultures; strongly consider lumbar puncture 1
  • Hospitalize with empiric antibiotics (ampicillin plus cefotaxime or ceftriaxone) 1

Essential Diagnostic Testing

Urine Evaluation

• Obtain urine by catheterization or suprapubic aspiration for culture if urinalysis is positive 1
• Urinary tract infection is now the most common serious bacterial infection in febrile infants, with prevalence of 5-7% 3
• Bag specimens are acceptable for urinalysis screening only, but positive results require catheterized specimen for culture 1

Blood and CSF Testing

• Blood cultures are indicated for all febrile infants 8-60 days old 1
• Lumbar puncture decisions depend on age and risk stratification:
  • Mandatory for 8-21 day olds 1
  • Conditional for 22-60 day olds based on inflammatory markers and clinical assessment 1, 3
• If CSF cannot be obtained or is uninterpretable, hospitalization is required in a facility with experienced neonatal staff 1

Antimicrobial Therapy Decisions

When to Initiate Antibiotics

• All infants 8-21 days old receive empiric antibiotics pending cultures 1
• Infants 22-60 days old with abnormal inflammatory markers or positive urinalysis receive antibiotics 1
• Low-risk infants 29-60 days old managed at home may receive parenteral ceftriaxone as a safety measure 1

When to Discontinue Antibiotics

• Discontinue after 24-36 hours if all cultures are negative, infant is clinically well or improving, and no other infection requires treatment 1
• Note that 15-18% of bacterial pathogens may not be detected by 24 hours, and 5-7% take longer than 36 hours 1
• Continue targeted therapy for culture-proven infections based on organism sensitivities and clinical response 1

Critical Pitfalls to Avoid

Hospitalization vs. Home Management

• Never send home an infant without CSF data unless they meet strict low-risk criteria for their age group 1
• Ensure reliable follow-up within 24 hours for any infant managed at home 1
• Consider transportation barriers—institutions should provide travel vouchers for families with transportation insecurity 1
• Telemedicine may be appropriate for some follow-up visits 1

Special Considerations

• Viral illness does not exclude bacterial co-infection—only 58% of infants with bacteremia or bacterial meningitis appear clinically ill 3
• Enterovirus-positive CSF may allow for antibiotic discontinuation if CSF analysis is otherwise normal 1
• Herpes simplex virus should be considered in infants with vesicles or high clinical suspicion 5
• Post-immunization fever requires the same evaluation if temperature reaches ≥38.0°C 5

Shared Decision-Making Framework

When multiple management options exist (particularly for 22-60 day olds with normal inflammatory markers), engage parents in shared decision-making by discussing 1:

• Probability of serious bacterial infection based on specific risk factors
• Benefits of observation (avoiding invasive procedures, antibiotics, hospitalization costs)
• Risks of missed infection (progression to sepsis, meningitis)
• Family's ability to monitor and return for worsening symptoms
• Access to follow-up care and transportation

The balance between avoiding unnecessary interventions in low-risk infants while maintaining safety requires careful risk stratification using the most current evidence-based criteria 1, 2, 4.